A novel strategy to target metabolic dependencies in acute myeloid leukemia

Acute myeloid leukemia (AML) remains difficult to cure despite recent advances. Off-target side effects of drugs currently used lead to significant morbidity and mortality. There is recognition that in AML, there is an increased dependence on OXPHOS metabolism, especially in the leukemia stem cell compartment (AML-LSC). It is also recognized that there is potential to exploit this vulnerability to treat AML. Drug re-purposing screens have suggested the potential use of artesunate (ART) to inhibit mitochondrial respiration. We have explored the potential role of ART as an additive agent in treating AML in combination with conventional therapy. Through in-vitro and in-vivo mouse model studies, we demonstrate the mechanism and efficacy of these combinations and their potential to overcome venetoclax resistance. We further demonstrate the specificity of these combinations with minimal off-target effects on normal hematopoietic stem cells (HSC). These observations warrant exploration of the additive role of ART in clinical trials.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2025-11-04
DOI
https://doi.org/10.1038/s41419-025-08129-3
Citations
2
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
3.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel strategy to target metabolic dependencies in acute myeloid leukemia

Radhakrishnan Rajesh, Poonkuzhali Balasubramanian, Hamenth Kumar Palani, Eunice Sindhuvi Edison et al.
2 citations
Cell Death and Disease
Acute Myeloid Leukemia Research
3.54
article

A novel strategy to target metabolic dependencies in acute myeloid leukemia

Radhakrishnan Rajesh, Poonkuzhali Balasubramanian, Hamenth Kumar Palani, Eunice Sindhuvi Edison, Matthew D. Solomon, Aby Abraham, Nithya Balasundaram, Clément Regnault, Anu Korula, Arvind Venkatraman, Vikram Mathews, Mohammed Yasar, Biju George, Uday Kulkarni, Yolanda Augustin, Sanjeev Krishna, Swathy Palani Kumar, Abirami Rajasekaran, Shruthi Pichandi
article en
2 citations

Abstract

Acute myeloid leukemia (AML) remains difficult to cure despite recent advances. Off-target side effects of drugs currently used lead to significant morbidity and mortality. There is recognition that in AML, there is an increased dependence on OXPHOS metabolism, especially in the leukemia stem cell compartment (AML-LSC). It is also recognized that there is potential to exploit this vulnerability to treat AML. Drug re-purposing screens have suggested the potential use of artesunate (ART) to inhibit mitochondrial respiration. We have explored the potential role of ART as an additive agent in treating AML in combination with conventional therapy. Through in-vitro and in-vivo mouse model studies, we demonstrate the mechanism and efficacy of these combinations and their potential to overcome venetoclax resistance. We further demonstrate the specificity of these combinations with minimal off-target effects on normal hematopoietic stem cells (HSC). These observations warrant exploration of the additive role of ART in clinical trials.

Cell Death and DiseaseVol. 16(1)
St George's, University of London (GB), Christian Medical College, Vellore (IN), St George’s University Hospitals NHS Foundation Trust (GB), Universitätsklinikum Tübingen (DE), Centre de Recherche Médicales de Lambaréné (GA), Christian Medical College (IN), de Duve Institute (BE), University of Glasgow (GB)
Department of Biotechnology, Ministry of Science and Technology, India, Anna University, Christian Medical College, Vellore, The Wellcome Trust DBT India Alliance, Directorate for Biological Sciences, National Centre for Biological Sciences
Openalex Percentile: Top 6%
Acute Myeloid Leukemia Research
3.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.